Project Grant 2339799

Award Date 1/1/24
Completion Date 12/31/28
Dollars Obligated $509K
Federal Grant Program
47.074
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
This $117,074 federal Project Grant award was provided by the National Science Foundation (NSF) Division of Materials Research under the Mathematical and Physical Sciences (CFDA 47.049) program. The grant supports a research project led by Lehigh University focused on leveraging biomaterials to enhance the safety and efficacy of CRISPR gene editing tools. The key objectives are to: 1) determine how peptide-based nanoparticle formulation and properties impact CRISPR uptake, activity, and...
This National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) project grant award for $1,000,000 aims to characterize the molecular mechanisms by which the bridge helix (BH) region of the CRISPR-Cas9 and CRISPR-Cas12a enzymes contributes to DNA cleavage fidelity and mismatch tolerance. The research will leverage computational modeling and simulations to identify how BH allostery regulates the nuclease activity of these genome editing enzymes, with the goal of engineering...
This National Science Foundation Project Grant of $649,998 will fund research into adaptive and regulatory diversity in natural CRISPR-Cas systems from March 1, 2023 to February 29, 2028. The grant was awarded under the Biological Sciences program (CFDA 47.074) to further the program's goals of advancing the biological sciences and strengthening the Nation's scientific enterprise. The University of Washington will investigate the mechanisms by which diverse CRISPR systems acquire...
This Project Grant award of $968,613 from the National Science Foundation Division of Molecular and Cellular Biosciences supports research into developing a novel CRISPR synthetic biology tool for investigating and reprogramming alkaloid biosynthesis regulation in Catharanthus roseus. The award was made on March 1, 2021 to Northeastern University for work to be completed by December 31, 2024 under the Biological Sciences program (CFDA 47.074). A sub-award of $100,000 was also provided to...
The National Science Foundation (NSF) has awarded a $240,000 Project Grant to The Johns Hopkins University under the Biological Sciences program (CFDA 47.074) to explore novel interactions between CRISPR-Cas systems and temperate bacteriophages. This 5-year project aims to investigate how CRISPR-Cas immunity systems, which protect bacteria from viral invaders, can exploit the lifecycle of temperate phages to acquire new defensive memories. The research will test hypotheses around CRISPR-Cas...
This five-year $385,645 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) will fund research investigating RNA-guided nucleases encoded by transposons across the three domains of life. The grantee, Columbia University, will examine an ancestral family of transposon-encoded enzymes that use guide RNAs to target and cut matching DNA sequences. These enzymes are directly related to CRISPR-Cas9 and CRISPR-Cas12 genome editing tools. The project aims to...
The National Science Foundation (NSF) awarded a $800,000 Project Grant under its Biological Sciences program (CFDA 47.074) to The Regents of the University of California, doing business as University of California, Berkeley. The grant funding will support collaborative research to discover and characterize compact CRISPR gene editing systems that can be encoded in plant viruses. This will enable more efficient and widespread deployment of genome editing capabilities across a variety of crop...
This $200,000 Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to improve the stability and sensitivity of a heat-resistant CRISPR-Cas13 enzyme system for enhanced RNA detection capabilities. The University of Connecticut is the prime awardee, and the project involves: Investigating the structure and mechanism of the thermostable Cas13 enzyme to enable rational engineering. Producing new Cas13 variants with superior thermostability,...
This $322,020 Project Grant award from the National Science Foundation's (NSF) Division of Integrative Organismal Systems will support collaborative research at the University of California, Davis (UC Davis) to develop improved methods for CRISPR/Cas9-based gene editing in maize. The key objectives are to generate maize lines expressing high levels of Cas9 nuclease and to engineer and optimize viral vectors to efficiently deliver guide RNAs for both somatic and heritable gene editing. This...
This $360,247 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research to investigate the molecular mechanisms underlying type III CRISPR-Cas adaptive immunity systems in bacteria and archaea. The research aims to understand the function and regulation of two major groups of signaling effectors associated with type III CRISPR systems: nucleases and membrane proteins. Using...

This $509,070 Project Grant award from the National Science Foundation's Division of Molecular and Cellular Biosciences (CFDA 47.074 Biological Sciences) supports research at Purdue University to explore the working mechanism of CRISPR-Cas12 endonucleases and analogues. The primary goals are to investigate the regulatory mechanisms of natural CRISPR inhibitor proteins, and to dissect the structural dynamics of newly identified Cas12 analogues found in mobile genetic elements and viruses. This research aims to expand knowledge in genome editing and promote community awareness of CRISPR technology. The project also includes an educational component to enrich understanding of CRISPR among students at Purdue, K-12 learners, and the general public through outreach programs. No subawards are planned under this award, which runs from January 1, 2024 through December 31, 2028.

Generated 10/29/24, 3:50 AM